Bottom line
Is HIBS a good fund? The bottom line
HIBS is an index leveraged & inverse ETF from Direxion.
Its expense ratio is 1.06% — about $106 a year on every $10,000 invested, cheaper than 65% of leveraged & inverse funds we track.
It returned −72.4% over one year, −55.6% a year over five years (as of Dec 31, 2025, per its prospectus).
With $22.6 million in net assets and 8 holdings, its largest position is Dreyfus (48.4%) and the top 10 make up 116.9% of the portfolio.
What to watch
- 5-year return in the bottom quarter of its category
- Concentrated: top 10 holdings are 116.9% of assets
- Small fund ($22.6 million) — small funds are likelier to close
Updated Nov 19, 2026
What HIBS invests in
The Fund seeks daily investment results, before fees and expenses, of 300% of the inverse (or opposite) of the daily performance of the Index. The Fund does not seek to achieve its stated investment objective for a period of time different than a trading day.
"The Index is provided by S&P Dow Jones Indices (the Index Provider). High Beta securities are defined by the Index Provider as the 100 securities from the S&P 500 Index that have exhibited the highest sensitivity to market movements, or beta, over the past 12 months as determined by the Index Provider based on the securities daily price changes. Securities with the highest beta are generally the most volatile securities in the S&P 500 Index. The Index Provider utilizes the daily price changes over the previous year to determine the beta of each security included in the S&P 500 Index and then ranks each security based on its calculated beta. The Index Provider excludes any security that does not have 252 days of daily price history. The Index is reviewed and rebalanced quarterly. As of December 31, 2025, the Index consisted of 100 components, which were concentrated in the information…
From the fund's prospectus (filed Mar 3, 2026).
HIBS performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| HIBS | −72.4% | −55.6% | — |
| Leveraged & Inverse median | −7.7% | −11.8% | −13.5% |
Source: Fund prospectus, as of Dec 31, 2025
What HIBS costs
On a $10,000 investment, HIBS's 1.06% expense ratio costs about $106 a year. The prospectus estimates $1,347 in total costs over 10 years (assuming 5% annual returns). The median leveraged & inverse fund charges 1.31%.
HIBS top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Dreyfus | 48.43% |
| 2 | Goldman Financial | 28.96% |
| 3 | Goldman Sachs Liq Es Fd A | 26.65% |
| 4 | N/a | 5.90% |
| 5 | N/a | 2.40% |
| 6 | N/a | 2.21% |
| 7 | N/a | 1.19% |
| 8 | N/a | 1.18% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 116.9% of the fund. See all top 25 holdings and asset mix →